Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PLYXPolaryx Therapeutics, Inc.

Nasdaq · CIK 0002075320
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts103

Identity from submissions API

NamePolaryx Therapeutics, Inc.
CIK0002075320
TickersPLYX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationWY WY
Phone201-940-7236
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
140 EAST RIDGEWOOD AVENUE
SUITE 415, SOUTH TOWER
PARAMUS
NJ
07652
NJ
Mailing address
SOUTH TOWER, 140 E RIDGEWOOD AVENUE
SUITE 415
PARAMUS
NJ
07652
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

36 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 10-Q QUARTERLY REPORT 0001213900-26-118950 001-43080 261547205 34 3614735 1 1
2026-09-14 8-K CURRENT REPORT 5.07 0001213900-26-099416 001-43080 261375592 34 197001 1 1
2026-09-01 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-26-096235 001-43080 261351244 34 218058 1 1
2026-08-13 10-Q QUARTERLY REPORT 0001213900-26-089118 001-43080 261273630 34 3619479 1 1
2026-07-28 ARS ARS 0001213900-26-082353 001-43080 261212856 34 5321989
2026-07-28 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-082345 001-43080 261212823 34 2095202
2026-07-28 DEF 14A PROXY STATEMENT 0001213900-26-082339 001-43080 261212804 34 6198757 1 1
2026-07-24 S-8 REGISTRATION STATEMENT 0001213900-26-081404 333-297686 261201852 33 193953 1 1
2026-07-21 8-K CURRENT REPORT 5.02 0001213900-26-080041 001-43080 261190580 34 191540 1 1
2026-07-17 8-K CURRENT REPORT 5.08,8.01 0001213900-26-078912 001-43080 261181884 34 193280 1 1
2026-05-28 4 xslF345X06/ownership.xml 0001213900-26-062322 7516
2026-05-28 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001213900-26-062155 001-43080 261036782 34 275068 1 1
2026-05-15 10-Q QUARTERLY REPORT 0001213900-26-056973 001-43080 26981485 34 3321075 1 1
2026-03-24 10-K ANNUAL REPORT 0001213900-26-033064 001-43080 26783579 34 30776746 1 1
2026-02-20 4 xslF345X05/ownership.xml 0001213900-26-018845 4549
2026-02-05 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-26-012759 005-95464 26602866 34 21980
2026-02-02 424B4 PROSPECTUS 0001213900-26-010761 333-291681 26587845 33 24368380
2026-01-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000339 333-291681 26580279 33 1792
2026-01-29 3 OWNERSHIP DOCUMENT 0001213900-26-009664 16281
2026-01-29 3 OWNERSHIP DOCUMENT 0001213900-26-009569 9673
2026-01-29 3 OWNERSHIP DOCUMENT 0001213900-26-009567 10997
2026-01-29 3 OWNERSHIP DOCUMENT 0001213900-26-009566 11028
2026-01-29 3 OWNERSHIP DOCUMENT 0001213900-26-009565 9754
2026-01-29 3 OWNERSHIP DOCUMENT 0001213900-26-009564 11127
2026-01-29 3 OWNERSHIP DOCUMENT 0001213900-26-009563 9693
2026-01-28 CERT PLYX_8A_Cert_2075320.pdf 0001354457-26-000098 001-43080 26570683 34 113451
2026-01-27 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-26-008173 001-43080 26564500 34 21407
2026-01-27 S-1/A REGISTRATION STATEMENT 0001213900-26-007973 333-291681 26562086 33 24823689 1 1
2026-01-14 S-1/A REGISTRATION STATEMENT 0001213900-26-004079 333-291681 26531194 33 24879565
2025-11-21 S-1 REGISTRATION STATEMENT 0001213900-25-113249 333-291681 251504340 33 25515488 1 1
2025-10-31 C-U xslC_X01/primary_doc.xml 0001213900-25-104723 020-36323 251441064 33 10687
2025-10-27 C-U xslC_X01/primary_doc.xml 0001213900-25-102529 020-36323 251419400 33 10671
2025-10-01 C/A xslC_X01/primary_doc.xml 0001213900-25-094743 020-36323 251365293 33 11658058
2025-09-19 DRS/A filename1.htm 0001213900-25-089144 377-08292 251324657 33 24548959
2025-09-03 C xslC_X01/primary_doc.xml 0001213900-25-084152 020-36323 251291105 33 11431403
2025-08-05 DRS filename1.htm 0001213900-25-072048 377-08292 251184648 33 24013042

Latest XBRL company facts

One latest value per concept from companyfacts (103 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 49.85M 2026-10-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-24 0001213900-26-033064
ffd NetFeeAmt NetFeeAmt USD 1,196.3 2026-07-15 S-8 2026-07-24 0001213900-26-081404
ffd TtlFeeAmt TtlFeeAmt USD 1,196.3 2026-07-15 S-8 2026-07-24 0001213900-26-081404
ffd TtlOfferingAmt TtlOfferingAmt USD 8.66M 2026-07-15 S-8 2026-07-24 0001213900-26-081404
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-15 S-8 2026-07-24 0001213900-26-081404
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 783,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 52,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 23,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 114.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 467,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 467,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001213900-26-056973
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 4.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap Assets Assets USD 8.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap AssetsCurrent Assets, Current USD 8.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap Cash Cash USD 250,000 2025-01-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 8.44M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 8.44M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 560.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 49.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 49.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 90,000 2026-03-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 6.64M 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 998,000 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 250,000 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 4.74M 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 50,000 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 6.39M 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 250,000 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 250,000 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.186 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.027 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 18,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 7.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -8.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -8.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 313,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 31,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 143,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap InvestmentCompanyIssuanceOfSharesPerShare InvestmentCompanyIssuanceOfSharesPerShare USD/shares 1.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 10.00M 2026-05-31 2026 Q2 10-Q 2026-08-13 0001213900-26-089118
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 0.05 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap Liabilities Liabilities USD 999,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 8.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap LiabilitiesCurrent Liabilities, Current USD 999,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 9.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -6.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -7.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -7.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -7.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap NoninterestExpenseInvestmentAdvisoryFees Noninterest Expense Investment Advisory Fees USD 467,000 2024-10-01 2024-10-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 5.00M 2025-09-03 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001213900-26-056973
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap OperatingExpenses Operating Expenses USD 6.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -6.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 18.70M 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 1.50M 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 21,000 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap OtherAssetsCurrent Other Assets, Current USD 18,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap OtherExpenses Other Expenses USD 26.00M 2024-02-01 2024-02-29 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 169,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 40.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 152,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 65,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 20,000 2026-01-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 193,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 3.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -106.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 2.50M 2026-05-01 2026-05-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 4 2026-05-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 467,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.5 2024-10-18 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 150,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 2.09M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.85 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 4.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 5.60M 2023-05-01 2023-05-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum pure 0.15 2025-07-01 2025-08-29 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1.17 2025-01-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 7.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 1.25M 2023-05-01 2023-05-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 9.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 26.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 50,000 2025-12-31 2025 FY 10-K 2026-03-24 0001213900-26-033064
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 48.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 48.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118950

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →